Cobimetinib Uses, Dosage, Side Effects and Interactions
Cotellic
Cotellic was the first cobimetinib product the FDA approved, in November 2015. No generic is listed as tablets.
Cobimetinib is a targeted cancer medicine (a kinase inhibitor) used for melanoma with a BRAF V600E or V600K mutation, together with vemurafenib, and on its own for histiocytic neoplasms in adults.
Quick links
Ask Anything About CobimetinibType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Cobimetinib in Short
- Drug class Kinase Inhibitor How the FDA classifies it
What it treatsCobimetinib treats two types of cancer in adults. The brand Cotellic is approved for both. Melanoma: unresectable (can't be removed by surgery) or metastatic (spread) melanoma with a BRAF V600E or V600K mutation. It is used together with vemurafenib.
- How you get it Prescription only
- Comes asTablet (by mouth)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs143 interact 3 major, 97 moderate and 43 minor
- What Medicaid pays
- Cotellic (brand)$128.81 a tablet
- Generic launchMay 2030 Our estimate for the first generic of Cotellic
The Pharmacist’s Take
Cobimetinib (Cotellic) is a specialist targeted cancer tablet, on the market since about 2015 with no generic, that blocks MEK1 and MEK2, proteins that relay growth signals; it is paired with vemurafenib for BRAF V600E or V600K melanoma that cannot be removed or has spread, and used alone for histiocytic neoplasms (rare blood cell tumors). Side effects are common, mainly diarrhea, nausea, an acne-like rash and easy sunburn, and your team may pause or lower the dose. Call your team right away for vision changes, breathlessness or swelling, or unusual bleeding such as black stools. Expect regular heart, eye, skin, liver and muscle checks.
Key Takeaways From the HelloPharmacist Team
- Take it once a day, with or without food, for the first 21 days of each 28-day cycle, then take a week off.
- If you miss a dose or vomit after taking it, skip that dose and take the next one at the usual time.
- Protect your skin every day with covering clothes and broad-spectrum SPF 30 or higher sunscreen and lip balm, because sunburn comes on easily.
- Check with your pharmacist before any new medicine or supplement, since St. John's Wort, rifampin, itraconazole and some antibiotics can change its levels.
Patient Information Guide for Cobimetinib
What It’s Used For
Cobimetinib is a kinase inhibitor used for these cancers in adults:
- Cotellic, together with vemurafenib, for unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.
- Cotellic, as a single agent, for histiocytic neoplasms.
How It Works
Cobimetinib reversibly blocks MEK1 and MEK2. These are proteins in a signaling pathway that tells cells to multiply. BRAF V600E and V600K mutations keep that pathway constantly active.
Vemurafenib blocks a different protein in the same pathway. In lab and animal studies, using both drugs together caused more cancer cell death and slowed tumor growth more than either drug alone.
Drug Class
Drug Class
- Kinase Inhibitor
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Kinase Inhibitor
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Kinase Inhibitors
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Cobimetinib in the FDA’s index.
From our Patient Information GuideCobimetinib reversibly blocks MEK1 and MEK2. These are proteins in a signaling pathway that tells cells to multiply. BRAF V600E and V600K mutations keep that pathway constantly active. Read How Cobimetinib Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Cobimetinib in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Mitogen-activated protein kinase (MEK) inhibitors
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Cotellic is a tablet taken by mouth once a day for the first 21 days of each 28-day cycle. Treatment continues until the cancer progresses or side effects become unacceptable.
- Take it with or without food.
- If you miss a dose or vomit after taking it, skip it and take the next scheduled dose.
- Your doctor may lower your dose or pause treatment if side effects occur.
Follow your prescriber's instructions and the label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Melanoma (skin cancer) that cannot be removed or has spread
For adults · Recommended dose
Usual dose 60 mg once a day
- 60 mg (three 20 mg tablets) orally taken once daily for the first 21 days of each 28-day cycle until disease progression or unacceptable toxicity
Good to know
Take with or without food
Histiocytic neoplasms (rare blood cell tumors)
For adults · Recommended dose
Usual dose 60 mg once a day
- 60 mg (three 20 mg tablets) orally taken once daily for the first 21 days of each 28-day cycle until disease progression or unacceptable toxicity
Good to know
Take with or without food
Short-term (14 days or less) concurrent use of moderate CYP3A inhibitors, unavoidable, in patients taking cotellic 60 mg
For adults who must briefly take a moderate CYP3A inhibitor
Usual dose 20 mg
Step by step
- Reduce Cotellic dose to 20 mg
- After discontinuation of the moderate CYP3A inhibitor, resume Cotellic 60 mg
Good to know
Patients already on a reduced dose (40 or 20 mg daily) should use an alternative to a strong or moderate CYP3A inhibitor
Special Situations
If side effects need a lower dose
Your doctor decides whether to lower your dose for side effects. Never change your dose on your own.
-
First dose reduction
40 mg orally once daily
-
Second dose reduction
20 mg orally once daily
Dose reduction, subsequent modification
Permanently discontinue Cotellic if unable to tolerate 20 mg orally once daily
Side Effects
The most common side effects reported in people with melanoma (taking it with vemurafenib) include:
Common side effects
- Diarrhea
- Nausea
- Vomiting
- Sun sensitivity (easy sunburn or rash in sunlight)
- Fever
- Acne-like skin rash
- Tiredness
- Swelling (edema)
When to get medical help
- Call your doctor right away for any unusual or serious bleeding, such as black stools, blood in urine, vomiting blood or a severe headache.
- Get help for new or worsening vision changes. This can signal fluid under the retina or a blocked retinal vein.
- Report shortness of breath, swelling or tiredness that could signal heart muscle weakness (cardiomyopathy).
- Call your doctor about a severe rash or other severe skin reaction.
- Report muscle pain, tenderness or weakness, which can signal rhabdomyolysis (muscle breakdown).
- Tell your doctor about any new skin growths or suspicious skin changes, including up to 6 months after your last dose.
- Report signs of liver problems, which your doctor will also check with blood tests.
- Tell your doctor right away if you become pregnant.
In histiocytic neoplasms, common side effects also include acne-like rash, tiredness, swelling, dry skin, itching, infections and shortness of breath. Contact your doctor promptly about bleeding, vision changes, severe rash, muscle pain or heart-related symptoms.
Warnings and Precautions
- New cancers: skin and other cancers can occur. Skin checks are done before treatment, every 2 months during treatment and for 6 months after.
- Bleeding: serious bleeding can occur, including in the brain or stomach and intestines.
- Heart muscle weakness: heart function is checked before treatment, after one month, then every 3 months.
- Severe rash and sun sensitivity: avoid sun and use protection.
- Eye problems: regular eye exams are needed. The drug is stopped permanently for retinal vein occlusion.
- Liver and muscle: blood tests are done monthly for the liver and periodically for CPK and creatinine.
- Pregnancy: can cause fetal harm.
Interactions
Cobimetinib is broken down by the liver enzyme CYP3A, so some drugs change its levels.
- Strong or moderate CYP3A inhibitors (such as itraconazole, erythromycin, ciprofloxacin) can raise levels. Avoid them if possible.
- Strong or moderate CYP3A inducers (such as carbamazepine, efavirenz, phenytoin, rifampin, St. John's Wort) can sharply lower levels and reduce effectiveness. Avoid them.
Interactions Listed in the FDA-Approved Label
From the Cobimetinib prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong or moderate CYP3A inhibitors For example: itraconazole, erythromycin, ciprofloxacinWhat happensItraconazole (a strong CYP3A4 inhibitor) increased cobimetinib systemic exposure by 6.7-fold.What to doAvoid concurrent use. If short-term (14 days or less) use of a moderate inhibitor is unavoidable in patients taking 60 mg, reduce COTELLIC to 20 mg, then resume the previous dose after stopping it. Use an alternative in patients on a reduced dose (40 or 20 mg daily).
-
Strong or moderate CYP3A inducers For example: carbamazepine, efavirenz, phenytoin, rifampin, St. John's WortWhat happensA strong CYP3A inducer may decrease cobimetinib systemic exposure by more than 80% and reduce its efficacy.What to doAvoid concurrent use of COTELLIC and strong or moderate CYP3A inducers.
Read the label’s full interactions text
7 DRUG INTERACTIONS Avoid concomitant administration of COTELLIC with strong or moderate CYP3A inducers or inhibitors. 7.1 Effect of Strong or Moderate CYP3A Inhibitors on COTELLIC Coadministration of COTELLIC with itraconazole (a strong CYP3A4 inhibitor) increased cobimetinib systemic exposure by 6.7-fold. Avoid concurrent use of COTELLIC and strong or moderate CYP3A inhibitors. If concurrent short term (14 days or less) use of moderate CYP3A inhibitors including certain antibiotics (e.g., erythromycin, ciprofloxacin) is unavoidable for patients who are taking COTELLIC 60 mg, reduce COTELLIC dose to 20 mg. After discontinuation of a moderate CYP3A inhibitor, resume COTELLIC at the previous dose. Use an alternative to a strong or moderate CYP3A inhibitor in patients who are taking a reduced dose of COTELLIC (40 or 20 mg daily). 7.2 Effect of Strong or Moderate CYP3A Inducers on COTELLIC Coadministration of COTELLIC with a strong CYP3A inducer may decrease cobimetinib systemic exposure by more than 80% and reduce its efficacy. Avoid concurrent use of COTELLIC and strong or moderate CYP3A inducers including but not limited to carbamazepine, efavirenz, phenytoin, rifampin, and St. John's Wort.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Tell your doctor about heart, eye or liver problems.
- Melanoma needs a confirmed BRAF V600E or V600K mutation.
- Avoid pregnancy. Use effective contraception during treatment and for 2 weeks after.
- Do not breastfeed during treatment and for 2 weeks after.
- It may reduce fertility in women and men.
- Not established for children.
- Not enough data in people 65 and older to know if they respond differently.
- No dose adjustment for mild to moderate kidney problems or any level of liver problems. A dose has not been set for severe kidney problems.
Half-Life and How Your Body Processes It
Cobimetinib is absorbed after you swallow it. Peak blood levels occur after about 2.4 hours, and a high-fat meal does not change absorption. Levels build up and reach steady state in about 9 days.
It is broken down mainly by the liver enzymes CYP3A and UGT2B7. Its half-life is about 44 hours. Most of it leaves in the stool, and very little leaves through the kidneys.
Storage
Store at room temperature below 30°C (86°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Cobimetinib
From the licensed clinical database we use, rolled up per supplement, most serious first.143 supplements and herbal products have documented interactions with Cobimetinib in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 3Major
- 97Moderate
- 43Minor
- ACTIVATED CHARCOALMajor
- GRAPEFRUITMajor
- ST. JOHN'S WORTMajor
- 7,8-BENZOFLAVONEModerate
- ACACIA RIGIDULAModerate
- ADRAFINILModerate
- AFRICAN WILD POTATOModerate
- AMERICAN ELDERModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Cobimetinib: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Cobimetinib — the kind of thing our pharmacy team would talk through with you at the counter.
What is Cotellic for?
How do I take it?
What side effects should I expect?
When should I call my doctor right away?
How should I protect my skin?
Can I take it if I might get pregnant?
Is cobimetinib available over the counter?
When was cobimetinib first available?
What is the brand name of cobimetinib?
What is the generic name of Cotellic?
What drug class is cobimetinib?
What strengths does cobimetinib come in?
How much does cobimetinib cost?
Is there a cobimetinib shortage?
Where can I read the cobimetinib prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Cobimetinib
Skip the scrolling. Ask in your own words and get an answer from Cobimetinib’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Cobimetinib’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Cobimetinib on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Cobimetinib Forms and Strengths (How It Comes)
Cobimetinib comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Cobimetinib inactive ingredients by manufacturer.
Tablet
How this form is used
- Cotellic is used with vemurafenib for unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.
- Cotellic is used as a single agent for adults with histiocytic neoplasms.
- Cotellic is taken by mouth once daily for the first 21 days of each 28-day cycle.
- Cotellic can be taken with or without food.
- If a Cotellic dose is missed or you vomit after taking it, resume with the next scheduled dose.
Cobimetinib on the U.S. Market: Products, Makers and Brands
How Cobimetinib appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 1 Cobimetinib product record with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2015. The one brand name in the directory today is Cotellic; the rest are generics.
How Widely Cobimetinib Is Used (Medicaid Data)
How many Cobimetinib prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Cobimetinib prescribed? Of the 1,682 medications we measure, Cobimetinib ranks #1,538 by Medicaid prescriptions — more than 9% of them.
Utilization by Cobimetinib product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
cobimetinib 20 MG Oral Tablet
1 of 2 listed NDCs had Medicaid claims. RxNorm 1722370
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Cobimetinib NDCs had Medicaid claims.
Compare Cobimetinib Products
A representative set of FDA-listed product records for Cobimetinib — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 20 mg | Oral | Genentech, Inc. | NDA | View NDC → |
Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Cobimetinib NDCs →
Cobimetinib Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Cobimetinib — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Cobimetinib in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Cobimetinib FDA Approval History
How Cobimetinib went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Cobimetinib Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Cobimetinib recalls since July 2021.
✅No Cobimetinib recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Cobimetinib in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 1
- Forms in current FDA listings
- 1 of 1
RxCUI 1722365 -
Dose form (SCDF) Oral TabletIn current FDA listings
RxCUI 1722369Its strength (SCD)-
20 mg
RxCUI 1722370
-
20 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Cobimetinib Supply and Shortage Status
Whether Cobimetinib is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Medicaid Pays for Cobimetinib
CMS’s weekly pharmacy survey (NADAC) has no price for Cobimetinib, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.
| Form | Strength | Version | What Medicaid paid | |
|---|---|---|---|---|
| Tablet · Oral | 20 mg | Cotellic (brand) | $128.81 per tablet | NDC details & Medicaid use |
Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.
Cobimetinib Brand Names
Cobimetinib has one brand name on record: Cotellic. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Cobimetinib: Manufacturers and Labelers
One company lists Cobimetinib products with the FDA. By number of product records, the largest are Genentech, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Cobimetinib Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Genentech, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →